daiichisankyo.us

Analisi sito web daiichisankyo.us

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

 Generato il Marzo 12 2026 17:06 PM

Statistiche non aggiornate? AGGIORNA !

Il punteggio e 54/100

SEO Content

Title

Passion for innovation. Compassion for patients.- Daiichi Sankyo US

Lunghezza : 67

Perfetto, il tuo title contiene tra 10 e 70 caratteri.

Description

Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.

Lunghezza : 130

Grande, la tua meta description contiene tra 70 e 160 caratteri.

Keywords

home, homepage, landing

Buono, la tua pagina contiene meta keywords.

Og Meta Properties

Buono, questa pagina sfrutta i vantaggi Og Properties.

Proprieta Contenuto
description Learn about who we are, our approach to scientific innovation, our areas of therapeutic focus, our products, commitments and more.
locale en_US
locale:alternate en_US
site_name DSI
title Passion for innovation. Compassion for patients.
type website
url https://daiichisankyo.us

Headings

H1 H2 H3 H4 H5 H6
1 34 0 0 0 0
  • [H1] Passion for Innovation. Compassion for Patients.®
  • [H2] Search Bar
  • [H2] Menu Display
  • [H2] Who We Are
  • [H2] Strategy
  • [H2] Purpose
  • [H2] Partners
  • [H2] Leadership
  • [H2] History
  • [H2] Patient Advocacy
  • [H2] Our Crafts
  • [H2] Compliance +
  • [H2] Transparency and Disclosure +
  • [H2] Corporate Grants and Giving +
  • [H2] Daiichi Sankyo Patient Support Programs
  • [H2] Supplier Diversity +
  • [H2] Transparency in Coverage
  • [H2] Rights & Protections Against Surprise Medical Bills
  • [H2] Our Science
  • [H2] Our Pipeline
  • [H2] Worldwide R&D Operations
  • [H2] Clinical Trial Information Disclosure
  • [H2] Expanded Access to Investigational Products
  • [H2] External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR)
  • [H2] Breadcrumb
  • [H2] Creating New Standards of Care
  • [H2] Our Stories
  • [H2] Asset Publisher
  • [H2] Transforming Science into Medicines
  • [H2] Striving to Create Optimized Antibody Drug Conjugate (ADC) Technology
  • [H2] What's New
  • [H2] Asset Publisher
  • [H2] A Pipeline Pushing Us to Become a Global Leader in Oncology
  • [H2] Work with a Purpose
  • [H2] Menu Display

Images

Abbiamo trovato 12 immagini in questa pagina web.

1 attributi alt sono vuoti o mancanti. Aggiungi testo alternativo in modo tale che i motori di ricerca possano comprendere meglio il contenuto delle tue immagini.

Text/HTML Ratio

Ratio : 37%

Ideale! Il rapporto testo/codice HTML di questa pagina e tra 25 e 70 percento.

Flash

Perfetto, non e stato rilevato contenuto Flash in questa pagina.

Iframe

Molto male, hai usato Iframes nelle tue pagine web, questo significa che in contenuto inserito negli Iframe non puo essere indicizzato.

URL Rewrite

Buono. I tuoi links appaiono friendly!

Underscores in the URLs

Abbiamo rilevato underscores nei tuoi URLs. Dovresti utilizzare trattini per ottimizzare le pagine per il tuo SEO.

In-page links

Abbiamo trovato un totale di 61 links inclusi 0 link(s) a files

Anchor Type Juice
Skip to content Interno Passing Juice
Healthcare Professionals Externo Passing Juice
Careers Interno Passing Juice
Contact Us Interno Passing Juice
Worldwide Externo Passing Juice
About Us Interno Passing Juice
Who We Are Interno Passing Juice
Strategy Interno Passing Juice
Purpose Interno Passing Juice
Partners Interno Passing Juice
Leadership Interno Passing Juice
History Interno Passing Juice
Patient Advocacy Interno Passing Juice
Our Crafts Interno Passing Juice
Compliance Interno Passing Juice
Standards Of Business Conduct Interno Passing Juice
Standards of Business Conduct & Ethics for Third Parties Interno Passing Juice
Daiichi Sankyo Group Global Anti-Bribery and Anti-Corruption Policy Interno Passing Juice
California Compliance Declaration Interno Passing Juice
California Supply Chains Act Interno Passing Juice
Daiichi Sankyo Group Employee Code of Conduct Interno Passing Juice
Transparency and Disclosure Interno Passing Juice
Post-marketing Commitments Interno Passing Juice
Working with Healthcare Professionals Interno Passing Juice
Vermont Pharmaceutical Marketer Price Disclosure Interno Passing Juice
Clinical Trial Information Disclosure Externo Passing Juice
Corporate Grants and Giving Interno Passing Juice
Independent Grants Interno Passing Juice
Sponsorships Interno Passing Juice
Charitable Contributions Interno Passing Juice
Daiichi Sankyo Requirements Interno Passing Juice
Corporate Support FAQs Interno Passing Juice
Daiichi Sankyo Patient Support Programs Interno Passing Juice
Supplier Diversity Interno Passing Juice
Supplier Registration Interno Passing Juice
Supplier Diversity FAQs Interno Passing Juice
Transparency in Coverage Interno Passing Juice
Rights & Protections Against Surprise Medical Bills Interno Passing Juice
Our Science Interno Passing Juice
Our Pipeline Externo Passing Juice
Worldwide R&D Operations Externo Passing Juice
Expanded Access to Investigational Products Externo Passing Juice
External Sponsored Research (ESR) Investigator Initiated Studies (IIS) and Collaborative Research (CR) Externo Passing Juice
Medicines Interno Passing Juice
Media Interno Passing Juice
Our Stories Interno Passing Juice
Home Interno Passing Juice
Learn More About Our Purpose Interno Passing Juice
View More Stories Interno Passing Juice
HER2 in Gynecologic Cancers—Why It Matters Interno Passing Juice
Showing Up for Patients: CARE Teams Inspire Hope in Their Communities Interno Passing Juice
Learn More About Our Science Interno Passing Juice
Explore the DXd ADC Technology Website Externo Passing Juice
View More News Interno Passing Juice
Patent Dispute Between Daiichi Sankyo and Seagen has Concluded Interno Passing Juice
ENHERTU Granted Priority Review in the US as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer Interno Passing Juice
Learn More About Our Medicines Interno Passing Juice
Terms & Conditions Interno Passing Juice
Privacy Notice Interno Passing Juice
Site Map Interno Passing Juice
Return Externo Passing Juice

SEO Keywords

Keywords Cloud

enhertu count decreased adverse metastatic reactions treatment patients dose cancer

Consistenza Keywords

Keyword Contenuto Title Keywords Description Headings
patients 159
enhertu 159
decreased 89
adverse 60
count 55

Usabilita

Url

Dominio : daiichisankyo.us

Lunghezza : 16

Favicon

Grande, il tuo sito usa una favicon.

Stampabilita

Non abbiamo riscontrato codice CSS Print-Friendly.

Lingua

Buono. La tua lingua dichiarata en.

Dublin Core

Questa pagina non sfrutta i vantaggi di Dublin Core.

Documento

Doctype

HTML 5

Encoding

Perfetto. Hai dichiarato che il tuo charset e UTF-8.

Validita W3C

Errori : 0

Avvisi : 0

Email Privacy

Attenzione! E stato trovato almeno un indirizzo mail in plain text. Usa antispam protector gratuito per nascondere gli indirizzi mail agli spammers.

Deprecated HTML

Grande! Non abbiamo trovato tags HTML deprecati nel tuo codice.

Suggerimenti per velocizzare

Eccellente, il tuo sito web non utilizza nested tables.
Molto male, il tuo sito web utilizza stili CSS inline.
Molto male, il tuo sito web ha troppi file CSS files (piu di 4).
Molto male, il tuo sito web ha troppi file JS (piu di 6).
Peccato, il vostro sito non approfitta di gzip.

Mobile

Mobile Optimization

Apple Icon
Meta Viewport Tag
Flash content

Ottimizzazione

XML Sitemap

Grande, il vostro sito ha una sitemap XML.

https://daiichisankyo.us/sitemap.xml

Robots.txt

https://daiichisankyo.us/robots.txt

Grande, il vostro sito ha un file robots.txt.

Analytics

Grande, il vostro sito ha uno strumento di analisi dei dati.

   Google Analytics

PageSpeed Insights

Dispositivo
Categorie

Free SEO Testing Tool

Free SEO Testing Tool e uno strumento di ottimizzazione per i motori di ricerca (seo tool) che serve per analizzare le tue pagine web